Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825566 | Clinical Therapeutics | 2014 | 7 Pages |
Abstract
The study could pave the way for approval of ramipril as a drug to treat children with Alport syndrome. Even though the study might not result in label changes, the EARLY PRO-TECT Alport trial provides the basis of an educational campaign to sensitize physicians, especially pediatricians, general practitioners, and nephrologists, to pay special attention to the early detection of kidney diseases in children, which could improve medical care for all children with kidney diseases.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Raees PhD, Ulrike PhD, Karsten PhD, Reinhard MD, Oliver MD,